<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="sgbs" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">sgbs</book-part-id>
      <title-group>
        <title>Simpson-Golabi-Behmel Syndrome Type 1</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Golabi</surname>
            <given-names>Mahin</given-names>
          </name>
          <degrees>MD, MPH</degrees>
          <aff>Clinical Geneticist, Medical Genetics and Pediatrics<break/>San Francisco General Hospital<break/>California Pacific Medical Center<break/>San Francisco, California</aff>
          <email>BrandtC@sutterhealth.org</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Leung</surname>
            <given-names>Alva</given-names>
          </name>
          <degrees>BS</degrees>
          <aff>Research Assistant, California Pacific Medical Center<break/>San Francisco, California</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lopez</surname>
            <given-names>Christina</given-names>
          </name>
          <degrees>BS</degrees>
          <aff>Research Assistant, California Pacific Medical Center<break/>San Francisco, California</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>19</day>
          <month>12</month>
          <year>2006</year>
        </date>
        <date date-type="updated">
          <day>23</day>
          <month>6</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="sickle" document-type="chapter">Sickle Cell Disease</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="stsl" document-type="chapter">Sitosterolemia</related-object>
      <abstract id="sgbs.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Simpson-Golabi-Behmel syndrome type 1 (SGBS1) is characterized by pre- and postnatal macrosomia; distinctive craniofacies (including macrocephaly, coarse facial features, macrostomia, macroglossia, palatal abnormalities); and commonly, mild to severe intellectual disability with or without structural brain anomalies. Other variable findings include supernumerary nipples, diastasis recti/umbilical hernia, congenital heart defects, diaphragmatic hernia, genitourinary defects, and GI anomalies. Skeletal anomalies can include vertebral fusion, scoliosis, rib anomalies, and congenital hip dislocation. Hand anomalies can include large hands and postaxial polydactyly. Affected individuals are at increased risk for embryonal tumors, including Wilms tumor, hepatoblastoma, adrenal neuroblastoma, gonadoblastoma, and hepatocellular carcinoma.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of SGBS1 is based on clinical findings, family history consistent with X-linked inheritance, and molecular genetic testing. <italic toggle="yes">GPC3</italic> and <italic toggle="yes">GPC4</italic> are the only two genes in which pathogenic variants are known to cause SGBS1.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Prompt treatment of neonatal hypoglycemia and airway obstruction resulting from micrognathia and glossoptosis. Care of cleft lip and/or cleft palate or macroglossia and related feeding difficulties, heart defects, skeletal abnormalities, and urogenital abnormalities by appropriate pediatric specialists. Speech therapy as needed. Neurodevelopmental assessment to determine need for special education, occupational therapy, and/or physical therapy.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> For those with congenital heart disease: anticoagulation and antibiotic prophylaxis as needed.</p>
          <p><italic toggle="yes">Surveillance:</italic> For hypoglycemia (newborn period); scoliosis (during accelerated growth); hearing and speech difficulties (especially in those with cleft palate); sleep apnea (especially for those with hypotonia and macroglossia, from newborn period through the end of the child&#x02019;s growth spurt); and Wilms tumor, gonadoblastoma, hepatocellular carcinoma, neuroblastoma, nephroblastomatosis, and hepatoblastoma (starting in the newborn period).</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Simpson-Golabi-Behmel syndrome type 1 is inherited in an X-linked manner. If the mother of the proband has a pathogenic variant, the chance of transmitting it in each pregnancy is 50%. Males who inherit the pathogenic variant will be affected; females who inherit the pathogenic variant will be carriers. Due to X-chromosome inactivation, carrier females may have manifestations of SGBS1. Males with SGBS1 will pass the pathogenic variant to all of their daughters and none of their sons. Carrier testing for at-risk relatives and prenatal testing for at-risk pregnancies may be available through laboratories offering either testing for the gene of interest or custom testing.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="sgbs.Diagnosis">
        <title>Diagnosis</title>
        <sec id="sgbs.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The diagnosis of Simpson-Golabi-Behmel syndrome type 1 (SGBS1) is based on clinical findings, family history consistent with X-linked inheritance, and molecular genetic testing.</p>
          <p>No clinical diagnostic criteria have been established. The diagnosis is suspected in males with the following:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Macrosomia</bold> (weight or length &#x02265;95th percentile when adjusted for sex and age)</p>
            </list-item>
            <list-item>
              <p>Characteristic facial features</p>
              <list list-type="bullet">
                <list-item>
                  <p>Macrocephaly (occipitofrontal circumference [OFC] &#x02265;95th percentile when adjusted for sex and age)</p>
                </list-item>
                <list-item>
                  <p>Ocular hypertelorism, epicanthal folds, and downslanting palpebral fissures</p>
                </list-item>
                <list-item>
                  <p>Redundant, furrowed skin over the glabella</p>
                </list-item>
                <list-item>
                  <p>Wide nasal bridge and anteverted nares in infants; broad nose and "coarse" facial appearance in older individuals</p>
                </list-item>
                <list-item>
                  <p>Macrostomia (abnormally large mouth)</p>
                </list-item>
                <list-item>
                  <p>Macroglossia (abnormally large tongue)</p>
                </list-item>
                <list-item>
                  <p>Dental malocclusion</p>
                </list-item>
                <list-item>
                  <p>Midline groove in the lower lip and/or deep furrow in the middle of the tongue</p>
                </list-item>
                <list-item>
                  <p>Cleft lip and/or submucous cleft palate (with a bifid uvula); high and narrow palate [<xref ref-type="bibr" rid="sgbs.REF.hughesbenzie.1996.227">Hughes-Benzie et al 1996</xref>]</p>
                </list-item>
                <list-item>
                  <p>Small mandible (micrognathia) in neonates; macrognathia in older individuals</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Multiple congenital anomalies</bold> (see <xref ref-type="sec" rid="sgbs.Clinical_Description">Clinical Description</xref>)</p>
              <list list-type="bullet">
                <list-item>
                  <p>Congenital heart disease</p>
                </list-item>
                <list-item>
                  <p>Conduction defects (transient QT interval prolongation)</p>
                </list-item>
                <list-item>
                  <p>Supernumerary nipples</p>
                </list-item>
                <list-item>
                  <p>Diastasis recti/umbilical hernia</p>
                </list-item>
                <list-item>
                  <p>Diaphragmatic hernia</p>
                </list-item>
                <list-item>
                  <p>Renal dysplasia/nephromegaly</p>
                </list-item>
                <list-item>
                  <p>Cryptorchidism/hypospadias</p>
                </list-item>
                <list-item>
                  <p>Hand anomalies (brachydactyly, cutaneous syndactyly, polydactyly)</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="sgbs.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p>
            <bold>Genes</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">GPC3,</italic> encoding glypican-3, was the first gene known to be associated with Simpson-Golabi-Behmel syndrome type 1 (SGBS1).</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">GPC4,</italic> encoding glypican-4, flanks the centromeric end of <italic toggle="yes">GPC3</italic> on Xq26 [<xref ref-type="bibr" rid="sgbs.REF.waterson.2010.3179">Waterson et al 2010</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="sgbs.T.summary_of_molecular_genetic_test" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Simpson-Golabi-Behmel Syndrome Type 1</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_2">Test Method</th>
                  <th id="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_3">Variants Detected&#x000a0;<sup>2</sup></th>
                  <th id="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_4" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Variant Detection Frequency by Test Method&#x000a0;<sup>3</sup></th>
                </tr>
                <tr>
                  <th headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_4" id="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Males</th>
                  <th headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_4" id="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Heterozygous Females</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">GPC3</italic>
                  </td>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_4 hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">37%-70%&#x000a0;<sup>5,&#x000a0;6,&#x000a0;7</sup></td>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_4 hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">(Multi)exon or whole-gene deletion&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_4 hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_2_1" rowspan="2" valign="middle" align="left" colspan="1">Unknown&#x000a0;<sup>11</sup></td>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_4 hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">GPC4</italic>
                  </td>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">(Multi)exon or whole-gene duplication</td>
                  <td headers="hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_1_4 hd_h_sgbs.T.summary_of_molecular_genetic_test_1_1_2_2" valign="middle" colspan="1" align="left" rowspan="1">Unknown</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="sgbs.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="sgbs" object-id="sgbs.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="sgbs.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="sgbs.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="sgbs.TF.1.3">
                <label>3. </label>
                <p>The ability of the test method used to detect a variant that is present in the indicated gene</p>
              </fn>
              <fn id="sgbs.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="sgbs.TF.1.5">
                <label>5. </label>
                <p>26/37 individuals with SGBS1 [<xref ref-type="bibr" rid="sgbs.REF.lin.1999.378">Lin et al 1999</xref>]; 7/10 [<xref ref-type="bibr" rid="sgbs.REF.veugelers.2000.1321">Veugelers et al 2000</xref>]; 7/19 [<xref ref-type="bibr" rid="sgbs.REF.li.2001.161">Li et al 2001</xref>]. Note: (1) <xref ref-type="bibr" rid="sgbs.REF.lin.1999.378">Lin et al [1999]</xref> hypothesized that the high detection rate may reflect sampling bias. (2) In the study by <xref ref-type="bibr" rid="sgbs.REF.li.2001.161">Li et al [2001]</xref>, two individuals clinically diagnosed with Perlman syndrome and <related-object link-type="booklink" source-id="gene" document-id="sotos" document-type="chapter">Sotos syndrome</related-object> prior to the availability of molecular genetic testing were found to have a <italic toggle="yes">GPC3</italic> pathogenic variant.</p>
              </fn>
              <fn id="sgbs.TF.1.6">
                <label>6. </label>
                <p>Lack of amplification by PCRs prior to sequence analysis can suggest a putative deletion of one or more exons or the entire X-linked gene in a male; confirmation may require additional testing by deletion/duplication analysis.</p>
              </fn>
              <fn id="sgbs.TF.1.7">
                <label>7. </label>
                <p>Includes the variant detection frequency using deletion/duplication analysis</p>
              </fn>
              <fn id="sgbs.TF.1.8">
                <label>8. </label>
                <p>Sequence analysis of genomic DNA cannot detect deletion of one or more exons or of the entire X-linked gene in a heterozygous female.</p>
              </fn>
              <fn id="sgbs.TF.1.9">
                <label>9. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="sgbs.TF.1.10">
                <label>10. </label>
                <p>A contiguous deletion of <italic toggle="yes">GPC3</italic> and <italic toggle="yes">GPC4</italic> has been identified in one family with SGBS1 [<xref ref-type="bibr" rid="sgbs.REF.veugelers.1998.1">Veugelers et al 1998</xref>].</p>
              </fn>
              <fn id="sgbs.TF.1.11">
                <label>11. </label>
                <p>Duplication of exons 1-9 in <italic toggle="yes">GPC4</italic> without deletion or mutation of <italic toggle="yes">GPC3</italic> was found in the original family described by <xref ref-type="bibr" rid="sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen [1984]</xref> in which no <italic toggle="yes">GPC3</italic> pathogenic variant had been identified [<xref ref-type="bibr" rid="sgbs.REF.waterson.2010.3179">Waterson et al 2010</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="sgbs.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis</bold> in an individual with findings consistent with SGBS1:</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Sequence analysis of <italic toggle="yes">GPC3</italic></p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>If no pathogenic variant is identified, deletion/duplication analysis of <italic toggle="yes">GPC3</italic></p>
            </list-item>
            <list-item>
              <label>3</label>
              <p>If no pathogenic variant in <italic toggle="yes">GPC3</italic> is detected, deletion/duplication analysis of <italic toggle="yes">GPC4</italic>.</p>
            </list-item>
          </list>
          <p><bold>Carrier testing for at-risk relatives</bold> requires prior identification of the pathogenic variant in the family.</p>
          <p>Note: (1) Carriers are heterozygotes for this X-linked disorder and may have clinical findings related to the disorder. (2) Identification of female carriers requires either (a) prior identification of the pathogenic variant in the family or, (b) if an affected male is not available for testing, molecular genetic testing first by sequence analysis, and then, if no pathogenic variant is identified, by methods to detect gross structural abnormalities<italic toggle="yes">.</italic></p>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the pathogenic variant in the family.</p>
        </sec>
      </sec>
      <sec id="sgbs.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="sgbs.Clinical_Description">
          <title>Clinical Description</title>
          <sec id="sgbs.Males">
            <title>Males</title>
            <p>Simpson-Golabi-Behmel syndrome type 1 (SGBS1) is characterized by pre- and postnatal macrosomia, distinctive facies, and variable visceral, skeletal, and neurodevelopmental abnormalities.</p>
            <p><bold>Macrosomia.</bold> Virtually all persons with SGBS1 have pre- and postnatal overgrowth. As with other macrosomic syndromes, hypoglycemia may be present in the neonatal period.</p>
            <p><bold>Macrocephaly.</bold> See <xref ref-type="sec" rid="sgbs.Clinical_Diagnosis">Clinical Diagnosis</xref>.</p>
            <p><bold>Characteristic facies.</bold> See <xref ref-type="sec" rid="sgbs.Clinical_Diagnosis">Clinical Diagnosis</xref>.</p>
            <p><bold>Eyes.</bold> Esotropia, cataracts, and coloboma of the optic disc [<xref ref-type="bibr" rid="sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</xref>] have been noted. Ocular nerve palsies and strabismus can occur.</p>
            <p><bold>Ears.</bold> Minor ear abnormalities are frequent, most often preauricular tags, fistulas, ear lobule creases, and helical dimples. Conductive hearing loss has been described [<xref ref-type="bibr" rid="sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</xref>].</p>
            <p><bold>Neck.</bold> Cystic hygroma has been described [<xref ref-type="bibr" rid="sgbs.REF.chen.1993.574">Chen et al 1993</xref>].</p>
            <p><bold>Thoracoabdominal wall.</bold> Supernumerary nipples are common, either one or multiple, unilateral or bilateral. Diastasis recti and umbilical hernias are observed frequently; however, true omphalocele is rare.</p>
            <p><bold>Cardiothoracic.</bold> Congenital heart defects are variable; septal defects are common. Pulmonic stenosis, aortic coarctation, transposition of the great vessels, and patent ductus arteriosus or patent foramen ovale have been reported.</p>
            <p>Conduction defects and arrhythmias have frequently been described [<xref ref-type="bibr" rid="sgbs.REF.lin.1999.378">Lin et al 1999</xref>]. Transient QT interval prolongation has been reported [<xref ref-type="bibr" rid="sgbs.REF.gertsch.2010.2379">Gertsch et al 2010</xref>].</p>
            <p><bold>Genitourinary.</bold> Nephromegaly, multicystic kidneys, hydronephrosis, hydroureter, and duplicated ureters are described. Other genitourinary anomalies include hypospadias, bifid scrotum, cryptorchidism, hydrocele, and inguinal hernia [<xref ref-type="bibr" rid="sgbs.REF.hughesbenzie.1996.227">Hughes-Benzie et al 1996</xref>].</p>
            <p><bold>Gastrointestinal.</bold> GI anomalies include pyloric ring, Meckel's diverticulum, intestinal malrotation [<xref ref-type="bibr" rid="sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</xref>], hepatosplenomegaly, pancreatic hyperplasia of islets of Langerhans, choledochal cysts [<xref ref-type="bibr" rid="sgbs.REF.kim.1999.267">Kim et al 1999</xref>], duplication of the pancreatic duct, and polysplenia.</p>
            <p><bold>Skeletal.</bold> Skeletal anomalies can include vertebral fusion, scoliosis, pectus excavatum, rib anomalies (including cervical ribs), winged scapula, congenital hip dislocation [<xref ref-type="bibr" rid="sgbs.REF.terespolsky.1995.329">Terespolsky et al 1995</xref>], small sciatic notches, and flared iliac wings [<xref ref-type="bibr" rid="sgbs.REF.chen.1993.574">Chen et al 1993</xref>]. Extra lumbar vertebrae, spina bifida occulta, coccygeal skin tag, and bony appendage have also been documented [<xref ref-type="bibr" rid="sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</xref>].</p>
            <p>Hand anomalies, including large hands, broad thumbs, and brachydactyly, are common. Other findings include syndactyly, clinodactyly, and postaxial polydactyly. Striking index finger hypoplasia with congenital abnormalities of the proximal phalanx has been reported [<xref ref-type="bibr" rid="sgbs.REF.day.2005.35">Day &#x00026; Fryer 2005</xref>]. Nail dysplasia, hypoplasia (particularly of the index finger), and hypoconvexity are common.</p>
            <p>Advanced bone age, including presence of ossified carpal bones in a newborn, has been described [<xref ref-type="bibr" rid="sgbs.REF.chen.1993.574">Chen et al 1993</xref>].</p>
            <p><bold>Central nervous system (CNS).</bold> Normal intelligence has been described, but mild to severe intellectual disability is common, with language delay being the most characteristic description.</p>
            <p>Neurologic manifestations are perhaps the most varied findings. Hypotonia and absent primitive reflexes, a high-pitched cry in neonates, seizures, and abnormal EEG have all been described.</p>
            <p>CNS malformations include agenesis of the corpus callosum, Chiari malformation and hydrocephalus [<xref ref-type="bibr" rid="sgbs.REF.young.2006.139">Young et al 2006</xref>], and aplasia of the cerebellar vermis.</p>
            <p><bold>Neoplasia.</bold> An absolute incidence and relative risk for tumors has not been established; however, in a review of more than 100 persons with SGBS1, <xref ref-type="bibr" rid="sgbs.REF.li.2001.161">Li et al [2001]</xref> found a tumor frequency of about 10%. At least five tumor types have been described [<xref ref-type="bibr" rid="sgbs.REF.lapunzina.1998.153">Lapunzina et al 1998</xref>, <xref ref-type="bibr" rid="sgbs.REF.li.2001.161">Li et al 2001</xref>, <xref ref-type="bibr" rid="sgbs.REF.lapunzina.2005.53">Lapunzina 2005</xref>]</p>
            <list list-type="bullet">
              <list-item>
                <p>Wilms tumor (4 cases)</p>
              </list-item>
              <list-item>
                <p>Hepatoblastoma (2)</p>
              </list-item>
              <list-item>
                <p>Adrenal neuroblastoma (1)</p>
              </list-item>
              <list-item>
                <p>Gonadoblastoma (1)</p>
              </list-item>
              <list-item>
                <p>Hepatocellular carcinoma (1)</p>
              </list-item>
            </list>
            <p>See <related-object link-type="booklink" source-id="gene" document-id="wilms-ov" document-type="chapter">Wilms Tumor Overview</related-object>.</p>
            <p>
              <bold>Other</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Diaphragmatic hernia and associated lung hypoplasia [<xref ref-type="bibr" rid="sgbs.REF.chen.1993.574">Chen et al 1993</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="cdh-ov" document-type="chapter">Congenital Diaphragmatic Hernia Overview</related-object>.</p>
              </list-item>
              <list-item>
                <p>Thymic hypoplasia and generalized lymphoid atrophy [<xref ref-type="bibr" rid="sgbs.REF.chen.1993.574">Chen et al 1993</xref>]</p>
              </list-item>
            </list>
          </sec>
          <sec id="sgbs.Heterozygous_Females">
            <title>Heterozygous Females</title>
            <p>Due to skewed X-chromosome inactivation, carrier females can have manifestations of SBGS including macrosomia, macrocephaly, hypertelorism, broad and upturned nasal tip with prominent columella, macrostomia, prominent chin, hypoplastic fingernails, coccygeal skin tag and bony appendage, extra lumbar and thoracic vertebrae, and accessory nipples [<xref ref-type="bibr" rid="sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen 1984</xref>]. Tall stature, course facial features, and developmental delay have also been reported [<xref ref-type="bibr" rid="sgbs.REF.gertsch.2010.2379">Gertsch et al 2010</xref>].</p>
            <p>Two female carriers with a <italic toggle="yes">GPC3</italic> pathogenic variant were reported to have two different types of cancer: one had a sero-papilliferous cystoadenoma, a low-grade ovarian carcinoma; the other had breast cancer [<xref ref-type="bibr" rid="sgbs.REF.gurrieri.2011.145">Gurrieri et al 2011</xref>]. Information was not sufficient to exclude other possible genetic causes for breast/ovarian cancer in the family.</p>
          </sec>
        </sec>
        <sec id="sgbs.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>In a study of genotype-phenotype correlations, <xref ref-type="bibr" rid="sgbs.REF.mariani.2003.225">Mariani et al [2003]</xref> determined that all deletions and single-nucleotide variants occurring in the eight <italic toggle="yes">GPC3</italic> exons result in loss of function with no phenotypic distinctions based on size or position of a deletion or single-nucleotide variant.</p>
        </sec>
        <sec id="sgbs.Penetrance">
          <title>Penetrance</title>
          <p>To date, all males with a <italic toggle="yes">GPC3</italic> pathogenic variant have had clinical findings of SGBS1 [Authors, personal observation].</p>
          <p>Penetrance in heterozygous females is unknown.</p>
        </sec>
        <sec id="sgbs.Nomenclature">
          <title>Nomenclature</title>
          <p>SGBS was initially described by <xref ref-type="bibr" rid="sgbs.REF.simpson.1975.18">Simpson et al [1975]</xref>, with later accounts by <xref ref-type="bibr" rid="sgbs.REF.golabi.1984.345">Golabi &#x00026; Rosen [1984]</xref> and <xref ref-type="bibr" rid="sgbs.REF.behmel.1984.409">Behmel et al [1984]</xref>.</p>
          <p>Terms no longer in use for SGBS:</p>
          <list list-type="bullet">
            <list-item>
              <p>Gigantism-dysplasia syndrome</p>
            </list-item>
            <list-item>
              <p>Encephalo-tropho-schisis syndrome</p>
            </list-item>
            <list-item>
              <p>Golabi-Rosen syndrome</p>
            </list-item>
            <list-item>
              <p>Simpson dysmorphia syndrome</p>
            </list-item>
          </list>
        </sec>
        <sec id="sgbs.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of SGBS1 is unknown; however, it is believed to be underdiagnosed [Author, personal observation].</p>
        </sec>
      </sec>
      <sec id="sgbs.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are known to be associated with pathogenic variants in <italic toggle="yes">GPC3</italic> and <italic toggle="yes">GPC4</italic>.</p>
      </sec>
      <sec id="sgbs.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Simpson-Golabi-Behmel syndrome type 2</bold>, also known as the infantile lethal variant, maps to Xp22 and is postulated to be a <bold>distinct disorder</bold> with overlapping phenotypic features. Clinical features described in four individuals include hydrops fetalis, jaundice, brisk deep tendon reflexes, seizures, and trilobate left lung [<xref ref-type="bibr" rid="sgbs.REF.terespolsky.1995.329">Terespolsky et al 1995</xref>, <xref ref-type="bibr" rid="sgbs.REF.brzustowicz.1999.779">Brzustowicz et al 1999</xref>]. <xref ref-type="bibr" rid="sgbs.REF.budny.2006.171">Budny et al [2006]</xref> identified a <italic toggle="yes">CXORF5</italic> pathogenic variant in one family.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="bws" document-type="chapter"><bold>Beckwith-Wiedemann syndrome</bold></related-object>
<bold>(BWS)</bold> is characterized by macrosomia, macroglossia, visceromegaly, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, rhabdomyosarcoma), omphalocele, neonatal hypoglycemia, ear creases/pits, adrenocortical cytomegaly, and renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly). BWS is associated with abnormal regulation of gene transcription by any one of a number of mechanisms in an imprinted domain on chromosome 11p15.5. BWS demonstrates the greatest number of clinical similarities with SGBS1 including macrosomia, macroglossia, ear anomalies, genitourinary malformations, and an increased incidence of tumors. However, the facies in these two syndromes are appreciably different, the skeletal abnormalities seen in SGBS1 are not present in BWS, and omphalocele seen in BWS is rare in SGBS1. Additionally, the X-linked inheritance of SGBS1 may help to differentiate these two overgrowth syndromes [<xref ref-type="bibr" rid="sgbs.REF.pilia.1996.241">Pilia et al 1996</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="sotos" document-type="chapter"><bold>Sotos syndrome</bold></related-object> is characterized by a typical facial appearance, intellectual impairment, and overgrowth involving both height and head circumference. It is associated with neonatal jaundice, scoliosis, seizures, strabismus, conductive hearing loss, congenital cardiac anomalies, renal anomalies, and behavioral problems. The risk for sacrococcygeal teratoma and neuroblastoma is slightly increased. About 80%-90% of individuals with Sotos syndrome have a demonstrable pathogenic variant or deletion of <italic toggle="yes">NSD1</italic>. Inheritance is autosomal dominant.</p>
        <p><bold>Weaver syndrome</bold> shares clinical features of overgrowth, umbilical hernia, ear anomalies, hypotonia, advanced bone age, vertebral defects, and hypertelorism, but has different facies and more prominent psychomotor delay. The diagnosis of Weaver syndrome is made on clinical grounds [<xref ref-type="bibr" rid="sgbs.REF.weaver.1974.547">Weaver et al 1974</xref>]. See <related-object link-type="booklink" source-id="gene" document-id="weaver" document-type="chapter"><italic toggle="yes">EZH2</italic>-Related Overgrowth</related-object>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="bcns" document-type="chapter"><bold>Nevoid basal cell carcinoma syndrome</bold></related-object>
<bold>(NBCCS, Gorlin syndrome)</bold> is characterized by multiple jaw keratocysts frequently beginning in the second decade of life and/or basal cell carcinomas usually from the third decade onwards. About 60% of individuals have a recognizable appearance with macrocephaly, bossing of the forehead, coarse facial features, and facial milia. Most individuals with NBCCS have skeletal anomalies such as bifid ribs or wedge-shaped vertebrae. Other less common findings include ectopic calcification, particularly in the falx; cardiac and ovarian fibromas; and medulloblastoma (primitive neuroectodermal tumor [PNET]) in early childhood. In about 60%-85% of individuals fulfilling diagnostic criteria, it is possible to identify a germline pathogenic variant of <italic toggle="yes">PTCH</italic>. Inheritance is autosomal dominant.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="fryns" document-type="chapter"><bold>Fryns syndrome</bold></related-object>, an autosomal recessive multiple congenital anomaly syndrome, is characterized by coarse facies, diaphragmatic hernia with lung hypoplasia, distal limb hypoplasia and malformations of the cardiovascular system, gastrointestinal system, genitourinary system (renal cystic dysplasia), and central nervous system (arrhinencephaly, Dandy-Walker anomaly, agenesis of the corpus callosum).</p>
        <p><bold>Other syndromes</bold> that may share overlapping features:</p>
        <list list-type="bullet">
          <list-item>
            <p>Perlman syndrome, a rare autosomal recessive condition, with macrosomia and a high incidence of Wilms tumor; facial features are distinctive and neonatal mortality is high.</p>
          </list-item>
          <list-item>
            <p>Nevo syndrome, an autosomal recessive condition that shares vertebral anomalies, ear malformations, cryptorchidism, overgrowth, and intellectual disability with SGBS1. Nevo syndrome manifestations further include accelerated osseous maturation, large extremities, and hypotonia. This condition is caused by pathogenic variants in exon 9 of <italic toggle="yes">PLOD1</italic> [<xref ref-type="bibr" rid="sgbs.REF.giunta.2005.158">Giunta et al 2005</xref>]. (See <related-object link-type="booklink" source-id="gene" document-id="eds6" document-type="chapter">Ehlers-Danlos Syndrome, Kyphoscoliotic Form</related-object>.)</p>
          </list-item>
          <list-item>
            <p>Marshall-Smith syndrome, which shares advanced bone age and intellectual disability with SGBS1; differences include facial features and predisposition to fractures.</p>
          </list-item>
          <list-item>
            <p>Elejalde syndrome (acrocephalopolydactylous dysplasia). Infrequently described, Elejalde syndrome includes findings of macrosomia, abnormal facies, craniosynostosis with acrocepaly, omphalocele, organomegaly, cystic renal dysplasia, and polydactyly.</p>
          </list-item>
          <list-item>
            <p>Infant of a diabetic mother syndrome. Infants born to diabetic mothers (IDM) have a higher rate of congenital malformations. Sacral agenesis or hypogenesis and/or caudal dysgenesis are classic findings [<xref ref-type="bibr" rid="sgbs.REF.williamson.1970.145">Williamson 1970</xref>], but other frequently observed anomalies include congenital heart defects, renal anomalies, vertebral anomalies, limb defects, and structural brain abnormalities.</p>
          </list-item>
          <list-item>
            <p>Mosaic trisomy 8. Phenotype is variable, with characteristic findings of advanced growth, long slender trunk with multiple skeletal abnormalities (spinal deformities, contractures of fingers and toes), absence of the corpus callosum, and moderate intellectual disability. Typical facial features include high, prominent forehead, hypertelorism, full lips, and micrognathia.</p>
          </list-item>
          <list-item>
            <p>Mosaic tetrasomy 12p (or Pallister-Killian syndrome), characterized by variegated skin pigmentation, facial anomalies including prominent forehead with sparse anterior scalp hair, ocular hypertelorism, short nose with anteverted nares, flat nasal bridge, as well as developmental delay</p>
          </list-item>
        </list>
      </sec>
      <sec id="sgbs.Management">
        <title>Management</title>
        <sec id="sgbs.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with Simpson-Golabi-Behmel syndrome type 1 (SGBS1), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment of neonates for hypoglycemia</p>
            </list-item>
            <list-item>
              <p>Assessment for upper airway sufficiency if macroglossia is present</p>
            </list-item>
            <list-item>
              <p>Evaluation of young children with hypotonia and macroglossia for sleep apnea</p>
            </list-item>
            <list-item>
              <p>Evaluation by a craniofacial team, including a feeding specialist if orofacial clefting is present</p>
            </list-item>
            <list-item>
              <p>Hearing evaluation</p>
            </list-item>
            <list-item>
              <p>Eye examination</p>
            </list-item>
            <list-item>
              <p>Cardiac evaluation for structural defects and conduction abnormalities including chest radiograph, electrocardiogram, and echocardiogram</p>
            </list-item>
            <list-item>
              <p>Renal ultrasound examination to evaluate for genitourinary malformations</p>
            </list-item>
            <list-item>
              <p>Abdominal/pelvic ultrasound examination to evaluate for intra-abdominal tumors</p>
            </list-item>
            <list-item>
              <p>Abdominal ultrasound examination to evaluate for visceral anomalies; further studies (e.g., MRI) if findings are suspicious</p>
            </list-item>
            <list-item>
              <p>Examination for evidence of skeletal anomalies requiring intervention (e.g., scoliosis during period of rapid growth rate)</p>
            </list-item>
            <list-item>
              <p>Development assessment including speech and language assessment</p>
            </list-item>
            <list-item>
              <p>Neurology evaluation / MRI of the brain if seizures are present</p>
            </list-item>
          </list>
        </sec>
        <sec id="sgbs.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Prompt treatment of hypoglycemia if present</p>
            </list-item>
            <list-item>
              <p>Prompt treatment of upper airway obstruction resulting from macroglossia, micrognathia, and/or glossoptosis</p>
            </list-item>
            <list-item>
              <p>Referral of children to the following pediatric specialists as needed:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Craniofacial team for management of cleft lip and/or palate, or macroglossia and related feeding difficulties</p>
                </list-item>
                <list-item>
                  <p>Audiologist, otolaryngologist, and speech therapy for management of hearing loss</p>
                </list-item>
                <list-item>
                  <p>Ophthalmologist for management of vision problems</p>
                </list-item>
                <list-item>
                  <p>Cardiologist for management of congenital heart defects and/or cardiac conduction defects</p>
                </list-item>
                <list-item>
                  <p>Orthopedist for the treatment of vertebral malformations and scoliosis if present</p>
                </list-item>
                <list-item>
                  <p>Urologist for surgical correction of anomalies such as hypospadias and cryptorchidism</p>
                </list-item>
                <list-item>
                  <p>Neurologist if seizures are present</p>
                </list-item>
                <list-item>
                  <p>Oncologist if a tumor is identified</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Neurodevelopmental follow up for individual treatment plan that may include special education, occupational therapy, and physical therapy</p>
            </list-item>
          </list>
        </sec>
        <sec id="sgbs.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Routine pre- and post-surgical preparation and monitoring for individuals with congenital heart disease and/or conduction defects</p>
        </sec>
        <sec id="sgbs.Surveillance">
          <title>Surveillance</title>
          <p>For males with SGBS1:</p>
          <list list-type="bullet">
            <list-item>
              <p>Monitoring for hypoglycemia in the newborn period</p>
            </list-item>
            <list-item>
              <p>Physical examination to monitor for scoliosis during period of rapid growth rate; radiographs as needed</p>
            </list-item>
            <list-item>
              <p>If development appears to be normal on initial assessment, routine monitoring of social and intellectual development</p>
            </list-item>
            <list-item>
              <p>Monitoring of renal function if renal anomalies are present</p>
            </list-item>
            <list-item>
              <p>Physical examinations to monitor for tumor risk [<xref ref-type="bibr" rid="sgbs.REF.lapunzina.2005.53">Lapunzina 2005</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Every three months until age four years</p>
                </list-item>
                <list-item>
                  <p>Every four months from age four to seven years</p>
                </list-item>
                <list-item>
                  <p>Biannually after age seven years</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>The following screening recommendations require further study to determine benefit. The clinician and family should discuss the methods to be used:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Wilms tumor.</bold> Abdominal ultrasound examination every three or four months from birth until at least age seven or eight years, and yearly thereafter [<xref ref-type="bibr" rid="sgbs.REF.choyke.1999.196">Choyke et al 1999</xref>, <xref ref-type="bibr" rid="sgbs.REF.lapunzina.2005.53">Lapunzina 2005</xref>]. Abdominal ultrasound examination should assess for both Wilms tumor and hepatic tumors.</p>
              <p>Note: When associated with an overgrowth syndrome, the risk for Wilms tumor decreases after age eight years [<xref ref-type="bibr" rid="sgbs.REF.beckwith.1998.268">Beckwith 1998</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Gonadoblastoma or hepatocellular carcinoma.</bold> Serial measurement of serum alpha fetoprotein and beta human chorionic gonadotropin concentrations with the following suggested frequency [<xref ref-type="bibr" rid="sgbs.REF.lapunzina.2005.53">Lapunzina 2005</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Every four months until age four years</p>
                </list-item>
                <list-item>
                  <p>Every six months between ages four and seven years</p>
                </list-item>
                <list-item>
                  <p>Annually after age seven years</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Neuroblastoma.</bold> Measurements of urinary catecholamine metabolites including vanillylmandelic acid and homovanillic acid as well as urinary free fractionated catecholamines with the following suggested frequency [<xref ref-type="bibr" rid="sgbs.REF.lapunzina.2005.53">Lapunzina 2005</xref>]:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Every four months until age four years</p>
                </list-item>
                <list-item>
                  <p>Every six months from age four to seven years</p>
                </list-item>
                <list-item>
                  <p>Annually after age seven years</p>
                  <p>Annual lifelong chest radiograms have also been suggested [<xref ref-type="bibr" rid="sgbs.REF.lapunzina.2005.53">Lapunzina 2005</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="sgbs.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>Early diagnosis of affected males in a family helps identify those who will benefit from early diagnosis and intervention to reduce morbidity and mortality.</p>
          <p>See <xref ref-type="sec" rid="sgbs.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="sgbs.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="sgbs.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="sgbs.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Simpson-Golabi-Behmel syndrome type 1 (SGBS1) is inherited in an X-linked manner.</p>
        </sec>
        <sec id="sgbs.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of an affected male will not have the disease nor will he be a carrier of the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>In a family with more than one affected individual, the mother of an affected male is an obligate carrier.</p>
            </list-item>
            <list-item>
              <p>If pedigree analysis reveals that the proband is the only affected family member, the mother may be a carrier or the affected male may have a <italic toggle="yes">de novo</italic> pathogenic variant, in which case the mother is not a carrier. The frequency of <italic toggle="yes">de novo</italic> pathogenic variants is not known.</p>
            </list-item>
            <list-item>
              <p>Because some female carriers have physical findings of SGBS1, physical examination of the proband's mother for features of SGBS1 is helpful.</p>
            </list-item>
            <list-item>
              <p>If a woman has more than one affected son and the pathogenic variant cannot be detected in her leukocyte DNA, she has germline mosaicism.</p>
            </list-item>
            <list-item>
              <p>When an affected male represents a simplex case (i.e., the only affected individual in the family), several possibilities regarding his mother's carrier status need to be considered:</p>
              <list list-type="bullet">
                <list-item>
                  <p>He has a <italic toggle="yes">de novo</italic> disease-causing alteration in <italic toggle="yes">GPC3</italic> or <italic toggle="yes">GPC4</italic> and his mother is not a carrier.</p>
                </list-item>
                <list-item>
                  <p>His mother has a <italic toggle="yes">de novo</italic> disease-causing alterations in <italic toggle="yes">GPC3</italic> or <italic toggle="yes">GPC4</italic>, either (a) as a "germline pathogenic variant" (i.e., present at the time of her conception and therefore in every cell of her body); or (b) as "germline mosaicism" (i.e., present in some of her germ cells only).</p>
                </list-item>
                <list-item>
                  <p>His mother has a pathogenic variant that she inherited from a maternal female ancestor.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to sibs depends on the carrier status of the mother.</p>
            </list-item>
            <list-item>
              <p>If the mother of the proband has a pathogenic variant, the chance of transmitting the pathogenic variant in each pregnancy is 50%. Male sibs who inherit the variant will be affected; female sibs who inherit the variant will be carriers and will usually not be affected.</p>
            </list-item>
            <list-item>
              <p>Germline mosaicism has been demonstrated. Thus, even if the pathogenic variant present in the proband has not been identified in the mother's DNA, sibs of the proband are still at increased risk of inheriting the pathogenic variant.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Males with SGBS1 will pass the pathogenic variant to all of their daughters and none of their sons. Thus, female offspring of the proband will be carriers, while male offspring of the proband will not be affected.</p>
          <p><bold>Other family members of a proband.</bold> The proband's maternal aunts may be at risk of being carriers and the aunt's offspring, depending on their gender, may be at risk of being carriers or of being affected.</p>
        </sec>
        <sec id="sgbs.Carrier_Detection">
          <title>Carrier Detection</title>
          <p>Carrier testing of at-risk female relatives is possible if the <italic toggle="yes">GPC3</italic> pathogenic variant has been identified in an affected family member.</p>
          <p>If the pathogenic variant has not been identified in the family, physical examination of at-risk female relatives and X-chromosome inactivation studies to determine if skewing of X-chromosome inactivation is present may identify some possible carriers [Author, personal observation].</p>
        </sec>
        <sec id="sgbs.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="sgbs.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="sgbs.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the pathogenic variant has been identified in a family member, prenatal testing is possible for a pregnancy at increased risk and preimplantation genetic diagnosis for SGBS1 are possible.</p>
        </sec>
      </sec>
      <sec id="sgbs.Resources">
        <title>Resources</title>
      </sec>
      <sec id="sgbs.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p>
          <bold>
            <italic toggle="yes">GPC3</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">GPC3</italic> comprises eight exons that span more than 500 kb. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="sgbs" object-id="sgbs.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> All eight exons of <italic toggle="yes">GPC3</italic> have been found to harbor either deletions or single-nucleotide variants that lead to the Simpson-Golabi-Behmel syndrome type 1 (SGBS1) phenotype.</p>
        <p>Approximately 50% of <italic toggle="yes">GPC3</italic> deletions involve exon 8 [<xref ref-type="bibr" rid="sgbs.REF.veugelers.2000.1321">Veugelers et al 2000</xref>]. Single-nucleotide variants include splice site, frameshift, missense, and nonsense variants [<xref ref-type="bibr" rid="sgbs.REF.veugelers.2000.1321">Veugelers et al 2000</xref>]. Single-nucleotide variants have been described in all exons; as expected, most occur in exon 3, the largest exon.</p>
        <p><bold>Normal gene product.</bold> Glypican-3 is a glycosylphosphatidylinositol-linked cell surface heparan sulfate proteoglycan [<xref ref-type="bibr" rid="sgbs.REF.pilia.1996.241">Pilia et al 1996</xref>]. Heparan sulfate proteoglycans bind and regulate the activities of a variety of extracellular ligands essential to cellular functions. Glypicans have a role in cell growth and cell division.</p>
        <p><bold>Abnormal gene product.</bold> The mechanism by which a pathogenic loss-of-function <italic toggle="yes">GPC3</italic> variant leads to the SGBS1 phenotype is unknown. At least 43% loss of functional <italic toggle="yes">GPC3</italic> protein is required to develop the SGBS1 phenotype in heterozygous females (total number of detection rate is unknown) [<xref ref-type="bibr" rid="sgbs.REF.yano.2011.466">Yano et al 2011</xref>].</p>
        <p>
          <bold>
            <italic toggle="yes">GPC4</italic>
          </bold>
        </p>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">GPC4</italic> is adjacent to the 3' end of <italic toggle="yes">GPC3</italic> and comprises nine exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="sgbs" object-id="sgbs.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> Duplication of exons 1-9 of <italic toggle="yes">GPC4</italic>
<bold>without</bold> a <italic toggle="yes">GPC3</italic> pathogenic variant leads to the SGBS1 phenotype [<xref ref-type="bibr" rid="sgbs.REF.waterson.2010.3179">Waterson et al 2010</xref>]. Note: Loss-of-function variants in <italic toggle="yes">GPC4</italic> are <bold>not</bold> associated with SGBS1 [<xref ref-type="bibr" rid="sgbs.REF.veugelers.2000.1321">Veugelers et al 2000</xref>].</p>
        <p><bold>Normal gene product.</bold> Glypican-4 is also a glycosylphosphatidylinositol-linked cell surface heparan sulfate proteoglycan [<xref ref-type="bibr" rid="sgbs.REF.veugelers.1998.1">Veugelers et al 1998</xref>].</p>
        <p><bold>Abnormal gene product.</bold> The mechanism by which a pathogenic loss-of-function <italic toggle="yes">GPC4</italic> variant leads to the SGBS1 phenotype is unknown.</p>
      </sec>
      <sec id="sgbs.References">
        <title>References</title>
        <sec id="sgbs.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="sgbs.Literature_Cited.reflist0">
            <ref id="sgbs.REF.beckwith.1998.268">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beckwith</surname>
                    <given-names>JB</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations.</article-title>
                <source>Am J Med Genet</source>
                <volume>79</volume>
                <fpage>268</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">9781906</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.behmel.1984.409">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Behmel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plochl</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenkranz</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>A new X-linked dysplasia gigantism syndrome: identical with the Simpson dysplasia syndrome?</article-title>
                <source>Hum Genet</source>
                <volume>67</volume>
                <fpage>409</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">6490008</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.budny.2006.171">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Budny</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Omran</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fliegauf</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tzschach</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wisniewska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raynaud</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoichet</surname>
                    <given-names>S A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Badura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenzner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latos-Bielenska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ropers</surname>
                    <given-names>H-H</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A novel X-linked recessive mental retardation syndrome comprising macrocephaly and ciliary dysfunction is allelic to oral-facial-digital type I syndrome.</article-title>
                <source>Hum. Genet.</source>
                <volume>120</volume>
                <fpage>171</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16783569</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.brzustowicz.1999.779">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brzustowicz</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khan</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Mapping of a new SGBS locus to chromosome Xp22 in a family with a severe form of Simpson-Golabi-Behmel syndrome.</article-title>
                <source>Am J Hum Genet</source>
                <volume>65</volume>
                <fpage>779</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">10441586</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.chen.1993.574">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cox</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golabi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Simpson-Golabi-Behmel syndrome: congenital diaphragmatic hernia and radiologic findings in two patients and follow-up of a previously reported case.</article-title>
                <source>Am J Med Genet</source>
                <volume>46</volume>
                <fpage>574</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8322824</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.choyke.1999.196">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choyke</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegel</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craft</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Green</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeBaun</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Screening for Wilms tumor in children with Beckwith-Wiedemann syndrome or idiopathic hemihypertrophy.</article-title>
                <source>Med Pediatr Oncol</source>
                <volume>32</volume>
                <fpage>196</fpage>
                <lpage>200</lpage>
                <pub-id pub-id-type="pmid">10064187</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.day.2005.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Day</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryer</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Index finger abnormalities in Simpson-Golabi-Behmel syndrome.</article-title>
                <source>Clin Dysmorphol.</source>
                <volume>14</volume>
                <fpage>35</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15602092</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.gertsch.2010.2379">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gertsch</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirmani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ackerman</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Babovic-Vuksanovic</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Transient QT interval prolongation in an infant with Simpson&#x02013;Golabi&#x02013;Behmel syndrome.</article-title>
                <source>Am J Med Genet Part A</source>
                <volume>152A</volume>
                <fpage>2379</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">20683991</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.giunta.2005.158">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Giunta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Randolph</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Gazali</surname>
                    <given-names>LI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraenzlin</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinmann</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA).</article-title>
                <source>Am J Med Genet A.</source>
                <volume>133A</volume>
                <fpage>158</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">15666309</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.golabi.1984.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Golabi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosen</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>A new X-linked mental retardation-overgrowth syndrome.</article-title>
                <source>Am J Med Genet.</source>
                <volume>17</volume>
                <fpage>345</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">6538755</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.gurrieri.2011.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gurrieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pomponi</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pietrobono</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lucci-Cordisco</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvestri</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storniello</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>The Simpson-Golabi-Behmel syndrome: A clinical case and a detective story.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>155A</volume>
                <fpage>145</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21204223</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.hughesbenzie.1996.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hughes-Benzie</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xuan</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golabi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurst</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobori</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marymee</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pagon</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Punnett</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schelley</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tolmie</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wohlferd</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grossman</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlessinger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacKenzie</surname>
                    <given-names>AE</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Simpson-Golabi-Behmel syndrome: genotype/phenotype analysis of 18 affected males from 7 unrelated families.</article-title>
                <source>Am J Med Genet</source>
                <volume>66</volume>
                <fpage>227</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">8958336</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.kim.1999.267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Idowu</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Choledochal cyst in Simpson-Golabi-Behmel syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>87</volume>
                <fpage>267</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">10564884</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.lapunzina.2005.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lapunzina</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Risk of tumorigenesis in overgrowth syndromes: a comprehensive review.</article-title>
                <source>Am J Med Genet C Semin Med Genet.</source>
                <volume>137C</volume>
                <fpage>53</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">16010678</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.lapunzina.1998.153">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lapunzina</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Badia</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galoppo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Matteo</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silberman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grichener</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes-Benzie</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>A patient with Simpson-Golabi-Behmel syndrome and hepatocellular carcinoma.</article-title>
                <source>J Med Genet</source>
                <volume>35</volume>
                <fpage>153</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9507397</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.li.2001.161">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shuman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fei</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cutiongco</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bender</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilkins-Haug</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Day-Salvatore</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yong</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geraghty</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Squire</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>102</volume>
                <fpage>161</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11477610</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.lin.1999.378">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes-Benzie</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Cardiac anomalies in the Simpson-Golabi-Behmel syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>83</volume>
                <fpage>378</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">10232747</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.mariani.2003.225">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mariani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iughetti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertorelli</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coviello</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pellegrini</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forabosco</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernasconi</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Genotype/phenotype correlations of males affected by Simpson-Golabi-Behmel syndrome with GPC3 gene mutations: patient report and review of the literature.</article-title>
                <source>J Pediatr Endocrinol Metab</source>
                <volume>16</volume>
                <fpage>225</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">12713262</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.pilia.1996.241">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pilia</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes-Benzie</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacKenzie</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baybayan</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>EY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huber</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forabosco</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schlessinger</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.</article-title>
                <source>Nat Genet</source>
                <volume>12</volume>
                <fpage>241</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8589713</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.simpson.1975.18">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Simpson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Landey</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>New</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>German</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1975</year>
                <article-title>A previously unrecognized X-linked syndrome of dysmorphia.</article-title>
                <source>Birth Defects Orig Artic Ser</source>
                <volume>11</volume>
                <fpage>18</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">1227524</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.terespolsky.1995.329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Terespolsky</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siegel-Bartelt</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weksberg</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Infantile lethal variant of Simpson-Golabi-Behmel syndrome associated with hydrops fetalis.</article-title>
                <source>Am J Med Genet.</source>
                <volume>59</volume>
                <fpage>329</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">8599356</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.veugelers.2000.1321">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Veugelers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cat</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muyldermans</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reekmans</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delande</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frints</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legius</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fryns</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schrander-Stumpel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weidle</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magdalena</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutational analysis of the GPC3/GPC4 glypican gene cluster on Xq26 in patients with Simpson-Golabi-Behmel syndrome: identification of loss-of-function mutations in the GPC3 gene.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>1321</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10814714</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.veugelers.1998.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Veugelers</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermeesch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marynen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>David</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>GPC4, the gene for human K-glypican, flanks GPC3 on xq26: deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome.</article-title>
                <source>Genomics</source>
                <volume>53</volume>
                <fpage>1</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">9787072</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.waterson.2010.3179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Waterson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockley</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Segal</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golabi</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Novel duplication in glypican-4 as an apparent cause of Simpson-Golabi-Behmel syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>152A</volume>
                <fpage>3179</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">21082656</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.weaver.1974.547">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weaver</surname>
                    <given-names>DD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graham</surname>
                    <given-names>CB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>IT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <article-title>A new overgrowth syndrome with accelerated skeletal maturation, unusual facies, and camptodactyly.</article-title>
                <source>J Pediatr.</source>
                <year>1974</year>
                <volume>84</volume>
                <fpage>547</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">4366187</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.williamson.1970.145">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>1970</year>
                <article-title>A syndrome of congenital malformations possibly due to maternal diabetes.</article-title>
                <source>Dev Med Child Neurol</source>
                <volume>12</volume>
                <fpage>145</fpage>
                <lpage>52</lpage>
                <pub-id pub-id-type="pmid">5418989</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.yano.2011.466">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yano</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baskin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagheri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moseley</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ray</surname>
                    <given-names>PN</given-names>
                  </name>
                </person-group>
                <article-title>Familial Simpson-Golabi-Behmel syndrome: studies of X-chromosome inactivation and clinical phenotypes in two female individuals with GPC3 mutations.</article-title>
                <source>Clin Genet.</source>
                <year>2011</year>
                <volume>80</volume>
                <fpage>466</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">20950395</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.young.2006.139">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wishnow</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nigro</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Expanding the clinical picture of Simpson-Golabi-Behmel syndrome.</article-title>
                <source>Pediatr Neurol</source>
                <volume>34</volume>
                <fpage>139</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">16458828</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="sgbs.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="sgbs.Suggested_Reading.reflist0">
            <ref id="sgbs.REF.gurrieri.1992.136">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gurrieri</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cappa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neri</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Further delineation of the Simpson-Golabi-Behmel (SGB) syndrome.</article-title>
                <source>Am J Med Genet</source>
                <volume>44</volume>
                <fpage>136</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">1456280</pub-id>
              </element-citation>
            </ref>
            <ref id="sgbs.REF.sapienza">
              <mixed-citation publication-type="book">Sapienza C, Hall JG. Genome imprinting in human disease. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G, eds. <italic toggle="yes">The Online Metabolic and Molecular Bases of Inherited Disease (OMMBID)</italic>. New York, NY: McGraw-Hill. Chap 15. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://ommbid.mhmedical.com/">online</ext-link>.</mixed-citation>
            </ref>
            <ref id="sgbs.REF.zarate.2009.1691">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zarate</surname>
                    <given-names>YA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mena</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>LJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steele</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tinkle</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkin</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Experience with hemihyperplasia and Beckwith-Wiedemann syndrome surveillance protocol.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>149A</volume>
                <fpage>1691</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19610116</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="sgbs.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="sgbs.Author_Notes">
          <title>Author Notes</title>
          <p>Mahin Golabi, MD, MPH, is board certified in Medical Genetics and Pediatrics, and former clinical professor in Clinical Genetics at University of California, San Francisco.</p>
        </sec>
        <sec id="sgbs.Author_History">
          <title>Author History</title>
          <p>Kathy Culver, MS; California Pacific Medical Center (2006-2011)Mahin Golabi, MD, MPH (2006-present)Aaron James; University of California San Francisco (2006-2011)Alva Leung, BS (2011-present)Christina Lopez, BS (2011-present)</p>
        </sec>
        <sec id="sgbs.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>23 June 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 December 2006 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>6 July 2006 (kc) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
